世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

中国医療保険市場:保険提供者タイプ別(公的Vs民間)、保障タイプ別(個人Vs家族)、購入形態別((保険会社、保険代理店/ブローカー、その他(Insurtech企業、第三者機関など))、保険料タイプ別(通常保険料、一回払い保険料)、地域別、競争予測と機会、2018-2028F


China Health Insurance Market By Type of Insurance Provider (Public Vs Private), By Type of Coverage (Individual Vs Family), By Mode of Purchase ((Insurance Companies, Insurance Agents/Brokers, and Others (Insurtech Companies, Third Party, etc.)), By Premium Type (Regular Premium, Single Premium), By Region, Competition Forecast & Opportunities, 2018-2028F

中国の医療保険市場は予測期間中に大きく成長すると予測される。この成長の原動力となるのは、慢性疾患の有病率の増加、健康保険に対する需要の高まり、保険適用を強化するための政府の取り組みといった要因であ... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
TechSci Research
テックサイリサーチ
2023年8月1日 US$3,500
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら
75 英語

 

サマリー

中国の医療保険市場は予測期間中に大きく成長すると予測される。この成長の原動力となるのは、慢性疾患の有病率の増加、健康保険に対する需要の高まり、保険適用を強化するための政府の取り組みといった要因である。さらに、健康保険プランが提供するベネフィットに対する認知度の高まりが、予測期間中の中国における健康保険業界の持続的成長に寄与するだろう。
健康保険は、被保険者の医療費、手術費、場合によっては歯科治療費をカバーする保険の一種である。不測の事態や高額な医療費に対する保障を提供する。通常、契約者は健康保険が支払いを引き継ぐ前に、合意された金額までの初期医療費を負担する責任がある。
中国全土で健康病患者が増加していることから、中国政府は公共の安全を確保するために必要な措置を講じている。また、健康保険の適用範囲を拡大し、医療制度を改善することにも重点が置かれている。中国における "Huiminbao "商品の開発は、中国の健康保険産業の成長に重要な役割を果たしている。2021年時点で、中国の総人口の95%以上、約13億6,000万人が基本的な健康保険に加入している。Huiminbaoは、地方政府と民間保険会社が特定の高額または深刻な医療費をカバーするために開始した医療保険の補足である。保険会社は、より良い医療サービスを提供するために、最新技術を活用し、ビッグデータ分析を活用するようになってきており、長期的な商業価値を生み出し、国内での医療保険需要の増加に貢献している。
Huiminbaoの商品の特徴は、包括的な給付、低い資金基準、幅広い保障範囲である。中・低所得者、特に高齢者やお年寄りは、こうした商品の恩恵を受けることができる。例えば、2021年には「北京匯民宝」が登場し、わずか28米ドルの年間保険料で年間43万1000米ドルの医療保険が提供された。ウォータードロップのプラットフォームでデビューして以来、300万人以上の顧客がこの商品でカバーされている。北京地方金融監督管理局、北京市医療保険局、CBIRC北京監督局は共同で北京匯民宝を監督している。このため、一般市民の福祉を目的とした政府の取り組みが活発化し、中国における医療保険市場の需要は予測期間中に増加すると予想される。
市場の成長は、健康保険料の増加によってさらに支えられる。健康保険料とは、保険契約の有効性を維持し、治療を受けるために保険会社に支払う定期的な支払いを指す。China Business NewsとPing An Health Insuranceによると、中国の健康保険料は2021年に1430億米ドルを超え、健康保険市場で最も注目される保険料となり、その割合は年々増加している。この要因は中国の健康保険業界の成長に寄与している。
さらに、健康リスクに対する意識の高まりも市場を牽引している。不健康なライフスタイルの選択により、がん、心血管疾患、糖尿病などの慢性疾患の有病率が上昇し、交通事故の頻度も増加している。健康リスクに対する意識の高まりは、特にコビッド19のパンデミック後に保険会社にチャンスをもたらしている。急速な高齢化と所得の増加に伴い、中国の医療制度の重要性はますます高まっている。所得水準が上がるにつれて、人々はより多くの資金を健康関連費用に充てようとする。例えば、中国の総医療費は2021年には10,850億米ドルに達し、国内総生産(GDP)の約6.6%を占めると予想されている。
さらに、医療費の増加が市場の成長を後押ししている。
医療保険の必要性は、主に医療費の高騰と、特に私立病院での高度な治療に伴う高額な費用から生じている。この地域は、病院や外科サービスのコスト上昇により、新たな財政的課題に直面している。これらの費用には、外科手術、医師の診察、入院、救急外来、診断検査など、さまざまな側面が含まれる。保険が適用されなければ、病院での治療費だけで個人の貯蓄が底をついてしまう。そのため、保障を充実させ、健康保険市場を支えるためには、健康保険への加入が不可欠となっている。近年、中国の医療業界では民間保険が重要視されており、2021年には民間保険料が医療費の11.6%以上を占めるようになる。
市場区分
中国の医療保険市場は、保険提供者の種類、保障の種類、購入形態、保険料の種類、地域、競争状況に基づいて区分される。保険提供者のタイプに基づき、市場は公的か民間かに二分される。保障の種類によって、市場は個人と家族に分けられる。購入形態に基づき、市場は保険会社、保険代理店/ブローカー、その他(インシュアテック企業、第三者機関など)に分けられる。)保険料タイプに基づき、市場は普通保険料ベースと一時払い保険料ベースに分けられる。
会社概要
Ping An Insurance (Group) Company of China Ltd、China Life Insurance (Overseas) Company Limited、China Pacific Insurance (Group) Co. Ltd.、People's Insurance Company of China、New China Life Insurance Co., Ltd.、China Reinsurance (Group) Corporation、AIA Group Limited、Azuria Life、Sino-German Allianz Life Insurance Co., Ltd.、HSBC Bank (China) Company Limitedなどが中国健康保険市場を牽引する主要企業である。
レポートの範囲
本レポートでは、中国の医療保険市場を以下のカテゴリーに分類し、さらに業界動向についても詳述しています:
- 中国の医療保険市場、保険提供者のタイプ別
o 公的
o 民間
- 中国健康保険市場:保険タイプ別
o 個人
家族
- 中国の医療保険市場:購入形態別
o 保険会社
o 保険代理店/ブローカー
o その他
- 中国の医療保険市場:保険料タイプ別
o レギュラー保険料
o シングル保険料
- 中国の医療保険市場:地域別
o 中南部
o 南西部
o 東部
o 北東部
o 西北
o 北
- 競合他社の状況
企業プロフィール:中国の医療保険市場に存在する主要企業の詳細分析。
利用可能なカスタマイズ:
TechSci Research社は、与えられた市場データをもとに、企業の特定のニーズに応じてカスタマイズを提供します。本レポートでは以下のカスタマイズが可能です:
企業情報
- 追加市場参入企業(最大5社)の詳細分析とプロファイリング

ページTOPに戻る


目次

1. Introduction
1.1. Product Overview
1.2. Key Highlights of the Report
1.3. Market Coverage
1.4. Market Segments Covered
1.5. Research Tenure Considered
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Market Overview
3.2. Market Forecast
3.3. Key Regions
3.4. Key Segments
4. Voice of Customer Analysis (B2C Model Analysis)
4.1. Sample Size Determination
4.2. Respondent Demographics
4.2.1. By Gender
4.2.2. By Age
4.2.3. By Occupation
4.3. Brand Awareness
4.4. Factors Influencing Purchase Decision
4.5. Sources of Information
5. China Health Insurance Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type of Insurance Provider Market Share Analysis (Public Vs Private)
5.2.2. By Type of Coverage Market Share Analysis (Individual Vs Family)
5.2.3. By Mode of Purchase Market Share Analysis (Insurance Companies, Insurance Agents/Brokers, Others (Insurtech Companies, Third Party, etc.)).
5.2.4. By Premium Type Market Share Analysis (Regular Premium, Single Premium)
5.2.5. By Regional Market Share Analysis
5.2.5.1. South-Central Market Share Analysis
5.2.5.2. South-West Market Share Analysis
5.2.5.3. East Market Share Analysis
5.2.5.4. North-East Market Share Analysis
5.2.5.5. North-West Market Share Analysis
5.2.5.6. North Market Share Analysis
5.2.6. By Top 5 Companies Market Share Analysis, Others (2022)
5.3. China Health Insurance Market Mapping & Opportunity Assessment
5.3.1. By Type of Insurance Provider Market Mapping & Opportunity Assessment
5.3.2. By Type of Coverage Market Mapping & Opportunity Assessment
5.3.3. By Mode of Purchase Market Mapping & Opportunity Assessment
5.3.4. By Premium Type Market Mapping & Opportunity Assessment
5.3.5. By Region Market Mapping & Opportunity Assessment
6. China Public Health insurance Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type of Coverage Market Share Analysis
6.2.2. By Mode of Purchase Market Share Analysis
6.2.3. By Premium Type Market Share Analysis
7. China Private Health insurance Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type of Coverage Market Share Analysis
7.2.2. By Mode of Purchase Market Share Analysis
7.2.3. By Premium Type Market Share Analysis
8. Market Dynamics
8.1. Drivers
8.1.1. Rising cost of medical services
8.1.2. Increasing number of daycare procedures
8.1.3. Government Initiatives.
8.2. Challenges
8.2.1. High cost of insurance premiums
8.2.2. Lack of awareness
9. Impact of COVID-19 on China Health Insurance Market
9.1. Impact Assessment Model
9.1.1. Key Segments Impacted
9.1.2. Key Regions Impacted
10. Market Trends & Developments
10.1. Advantages of health insurance policies
10.2. Increasing healthcare expenditure
10.3. Increasing online purchase
10.4. Rising health risks
10.5. Increasing numbers of health insurance plans
11. Porter’s Five Forces Model
11.1. Competitive Rivalry
11.2. Bargaining Power of Buyers
11.3. Bargaining Power of Suppliers
11.4. Threat of New Entrants
11.5. Threat of Substitutes
12. SWOT Analysis
12.1. Strengths
12.2. Weaknesses
12.3. Opportunities
12.4. Threats
13. Competitive Landscape
13.1. Company Profiles
13.1.1. Ping An Insurance (Group) Company of China Ltd
13.1.1.1. Company Details
13.1.1.2. Products
13.1.1.3. Financials (As Per Availability)
13.1.1.4. Key Market Focus & Geographical Presence
13.1.1.5. Recent Developments
13.1.1.6. Key Management Personnel
13.1.2. China Life Insurance (Overseas) Company Limited
13.1.2.1. Company Details
13.1.2.2. Products
13.1.2.3. Financials (As Per Availability)
13.1.2.4. Key Market Focus & Geographical Presence
13.1.2.5. Recent Developments
13.1.2.6. Key Management Personnel
13.1.3. China Pacific Insurance (Group) Co. Ltd.
13.1.3.1. Company Details
13.1.3.2. Products
13.1.3.3. Financials (As Per Availability)
13.1.3.4. Key Market Focus & Geographical Presence
13.1.3.5. Recent Developments
13.1.3.6. Key Management Personnel
13.1.4. People's Insurance Company of China
13.1.4.1. Company Details
13.1.4.2. Products
13.1.4.3. Financials (As Per Availability)
13.1.4.4. Key Market Focus & Geographical Presence
13.1.4.5. Recent Developments
13.1.4.6. Key Management Personnel
13.1.5. New China Life Insurance Co., Ltd
13.1.5.1. Company Details
13.1.5.2. Products
13.1.5.3. Financials (As Per Availability)
13.1.5.4. Key Market Focus & Geographical Presence
13.1.5.5. Recent Developments
13.1.5.6. Key Management Personnel
13.1.6. China Reinsurance (Group) Corporation
13.1.6.1. Company Details
13.1.6.2. Products
13.1.6.3. Financials (As Per Availability)
13.1.6.4. Key Market Focus & Geographical Presence
13.1.6.5. Recent Developments
13.1.6.6. Key Management Personnel
13.1.7. AIA Group Limited
13.1.7.1. Company Details
13.1.7.2. Products
13.1.7.3. Financials (As Per Availability)
13.1.7.4. Key Market Focus & Geographical Presence
13.1.7.5. Recent Developments
13.1.7.6. Key Management Personnel
13.1.8. Azuria Life
13.1.8.1. Company Details
13.1.8.2. Products
13.1.8.3. Financials (As Per Availability)
13.1.8.4. Key Market Focus & Geographical Presence
13.1.8.5. Recent Developments
13.1.8.6. Key Management Personnel
13.1.9. Sino-German Allianz Life Insurance Co., Ltd.
13.1.9.1. Company Details
13.1.9.2. Products
13.1.9.3. Financials (As Per Availability)
13.1.9.4. Key Market Focus & Geographical Presence
13.1.9.5. Recent Developments
13.1.9.6. Key Management Personnel
13.1.10. HSBC Bank (China) Company Limited
13.1.10.1. Company Details
13.1.10.2. Products
13.1.10.3. Financials (As Per Availability)
13.1.10.4. Key Market Focus & Geographical Presence
13.1.10.5. Recent Developments
13.1.10.6. Key Management Personnel
14. Strategic Recommendations/Action Plan
14.1. Key Focus Areas
14.2. Target Type of Coverage
14.3. Target Mode of Purchase
15. About Us & Disclaimer
(Note: The companies list can be customized based on the client requirements.)

 

ページTOPに戻る


 

Summary

The China health insurance market is projected to experience significant growth in the forecast period. This growth will be driven by factors such as the increasing prevalence of chronic diseases, growing demand for health insurance, and government efforts to enhance insurance coverage. Furthermore, the growing awareness of the benefits provided by health insurance plans will contribute to the sustainable growth of the health insurance industry in China during the forecast period.
Health insurance is a type of insurance that covers medical, surgical, and sometimes dental expenses for the insured person. It provides protection against unforeseen and expensive medical costs. Typically, the policyholder is responsible for covering initial medical expenses up to an agreed-upon amount before the health insurance takes over the payment.
Given the rising number of health disease cases nationwide, the Chinese government is taking necessary steps to ensure public safety. There is also a focus on expanding health insurance coverage and improving the healthcare system. The development of "Huiminbao" products in China has played a significant role in the growth of the country's health insurance industry. As of 2021, more than 95% of the total population in China, approximately 1.36 billion people, had basic health insurance coverage. Huiminbao is a medical insurance supplement launched by local governments and commercial insurance companies to cover certain large or serious medical expenses. Insurance companies are increasingly leveraging the latest technologies and utilizing big data analytics to deliver better healthcare services, which creates long-term commercial value and contributes to the increasing demand for health insurance in the country.
Huiminbao products are characterized by inclusive benefits, low financial thresholds, and broad protection coverage. Middle to low-income residents, especially seniors and the elderly, benefit from these products. For example, in 2021, "Beijing Huiminbao" was introduced, offering medical insurance coverage of up to USD 431,000 per year for an annual premium of just USD 28. Since its debut on the Waterdrop platform, over 3 million clients have been covered by this product. The Beijing Local Financial Supervision and Administration, the Beijing Municipal Medical Insurance Bureau, and the CBIRC's Beijing Supervisory Bureau jointly oversee Beijing Huiminbao. Therefore, with rising government initiatives aimed at the welfare of the general public, the market demand for health insurance in China is expected to increase during the forecast period.
The market growth is further supported by the increasing health insurance premiums. Health insurance premiums refer to the regular payments made to an insurer to maintain the validity of the policy and receive medical treatment. According to China Business News and Ping An Health Insurance, China's health insurance premiums exceeded USD 143 billion in 2021, making them the most notable in the health insurance market, with a growing percentage each year. This factor contributes to the growth of China's health insurance industry.
Moreover, the rising awareness of health risks also drives the market. Unhealthy lifestyle choices have led to an increase in the prevalence of chronic diseases such as cancer, cardiovascular disease, and diabetes, as well as an increase in the frequency of traffic accidents. The increased awareness of health risks presents opportunities for insurance companies, particularly in the aftermath of the Covid-19 pandemic. With a rapidly aging population and increasing income, China's healthcare system has become increasingly important. People are willing to allocate more funds to health-related expenses as their income levels rise. For instance, total health expenditure in China is expected to reach USD 1085 billion, accounting for approximately 6.6% of the gross domestic product (GDP) in 2021.
Additionally, the growth of the market is fueled by the increasing medical costs.
The need for health insurance primarily arises from the escalating medical expenses and high costs associated with advanced treatments, particularly in private hospitals. The region is facing a new financial challenge due to the rising costs of hospital and surgical services. These costs encompass various aspects, including surgical procedures, doctor consultations, hospital stays, emergency room visits, and diagnostic tests. Without insurance coverage, the expenses incurred from hospital care alone can deplete an individual's savings entirely. Consequently, obtaining health insurance has become imperative to enhance coverage and support the health insurance market. In recent years, private insurance has gained significant importance in China's healthcare industry, with private insurance premiums accounting for over 11.6% of healthcare expenditures in 2021.
Market Segmentation
China health insurance market is segmented based on the type of insurance provider, type of coverage, mode of purchase, premium type, region and competitive landscape. Based on the type of insurance provider, the market is bifurcated into public vs private. Based on the type of coverage, the market is divided into individual vs family. Based on the mode of purchase, the market is divided into insurance companies, insurance agents/brokers, and others (insurtech companies, third party, etc.)). Based on premium type, the market is divided into regular premium and single premium based.
Company Profiles
Ping An Insurance (Group) Company of China Ltd, China Life Insurance (Overseas) Company Limited, China Pacific Insurance (Group) Co. Ltd., People's Insurance Company of China, New China Life Insurance Co., Ltd, China Reinsurance (Group) Corporation, AIA Group Limited, Azuria Life, Sino-German Allianz Life Insurance Co., Ltd., and HSBC Bank (China) Company Limited are among the major players driving the China health insurance market.
Report Scope:
In this report, the China health insurance market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
• China Health Insurance Market, By Type of Insurance Provider:
o Public
o Private
• China Health Insurance Market, By Type of Coverage:
o Individual
o Family
• China Health Insurance Market, By Mode of Purchase:
o Insurance Companies
o Insurance Agents/Brokers
o Others
• China Health Insurance Market, By Premium Type:
o Regular Premium
o Single Premium
• China Health Insurance Market, By Region:
o South-Central
o South-West
o East
o North-East
o North-West
o North
• Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the China health insurance market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).



ページTOPに戻る


Table of Contents

1. Introduction
1.1. Product Overview
1.2. Key Highlights of the Report
1.3. Market Coverage
1.4. Market Segments Covered
1.5. Research Tenure Considered
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Market Overview
3.2. Market Forecast
3.3. Key Regions
3.4. Key Segments
4. Voice of Customer Analysis (B2C Model Analysis)
4.1. Sample Size Determination
4.2. Respondent Demographics
4.2.1. By Gender
4.2.2. By Age
4.2.3. By Occupation
4.3. Brand Awareness
4.4. Factors Influencing Purchase Decision
4.5. Sources of Information
5. China Health Insurance Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type of Insurance Provider Market Share Analysis (Public Vs Private)
5.2.2. By Type of Coverage Market Share Analysis (Individual Vs Family)
5.2.3. By Mode of Purchase Market Share Analysis (Insurance Companies, Insurance Agents/Brokers, Others (Insurtech Companies, Third Party, etc.)).
5.2.4. By Premium Type Market Share Analysis (Regular Premium, Single Premium)
5.2.5. By Regional Market Share Analysis
5.2.5.1. South-Central Market Share Analysis
5.2.5.2. South-West Market Share Analysis
5.2.5.3. East Market Share Analysis
5.2.5.4. North-East Market Share Analysis
5.2.5.5. North-West Market Share Analysis
5.2.5.6. North Market Share Analysis
5.2.6. By Top 5 Companies Market Share Analysis, Others (2022)
5.3. China Health Insurance Market Mapping & Opportunity Assessment
5.3.1. By Type of Insurance Provider Market Mapping & Opportunity Assessment
5.3.2. By Type of Coverage Market Mapping & Opportunity Assessment
5.3.3. By Mode of Purchase Market Mapping & Opportunity Assessment
5.3.4. By Premium Type Market Mapping & Opportunity Assessment
5.3.5. By Region Market Mapping & Opportunity Assessment
6. China Public Health insurance Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type of Coverage Market Share Analysis
6.2.2. By Mode of Purchase Market Share Analysis
6.2.3. By Premium Type Market Share Analysis
7. China Private Health insurance Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type of Coverage Market Share Analysis
7.2.2. By Mode of Purchase Market Share Analysis
7.2.3. By Premium Type Market Share Analysis
8. Market Dynamics
8.1. Drivers
8.1.1. Rising cost of medical services
8.1.2. Increasing number of daycare procedures
8.1.3. Government Initiatives.
8.2. Challenges
8.2.1. High cost of insurance premiums
8.2.2. Lack of awareness
9. Impact of COVID-19 on China Health Insurance Market
9.1. Impact Assessment Model
9.1.1. Key Segments Impacted
9.1.2. Key Regions Impacted
10. Market Trends & Developments
10.1. Advantages of health insurance policies
10.2. Increasing healthcare expenditure
10.3. Increasing online purchase
10.4. Rising health risks
10.5. Increasing numbers of health insurance plans
11. Porter’s Five Forces Model
11.1. Competitive Rivalry
11.2. Bargaining Power of Buyers
11.3. Bargaining Power of Suppliers
11.4. Threat of New Entrants
11.5. Threat of Substitutes
12. SWOT Analysis
12.1. Strengths
12.2. Weaknesses
12.3. Opportunities
12.4. Threats
13. Competitive Landscape
13.1. Company Profiles
13.1.1. Ping An Insurance (Group) Company of China Ltd
13.1.1.1. Company Details
13.1.1.2. Products
13.1.1.3. Financials (As Per Availability)
13.1.1.4. Key Market Focus & Geographical Presence
13.1.1.5. Recent Developments
13.1.1.6. Key Management Personnel
13.1.2. China Life Insurance (Overseas) Company Limited
13.1.2.1. Company Details
13.1.2.2. Products
13.1.2.3. Financials (As Per Availability)
13.1.2.4. Key Market Focus & Geographical Presence
13.1.2.5. Recent Developments
13.1.2.6. Key Management Personnel
13.1.3. China Pacific Insurance (Group) Co. Ltd.
13.1.3.1. Company Details
13.1.3.2. Products
13.1.3.3. Financials (As Per Availability)
13.1.3.4. Key Market Focus & Geographical Presence
13.1.3.5. Recent Developments
13.1.3.6. Key Management Personnel
13.1.4. People's Insurance Company of China
13.1.4.1. Company Details
13.1.4.2. Products
13.1.4.3. Financials (As Per Availability)
13.1.4.4. Key Market Focus & Geographical Presence
13.1.4.5. Recent Developments
13.1.4.6. Key Management Personnel
13.1.5. New China Life Insurance Co., Ltd
13.1.5.1. Company Details
13.1.5.2. Products
13.1.5.3. Financials (As Per Availability)
13.1.5.4. Key Market Focus & Geographical Presence
13.1.5.5. Recent Developments
13.1.5.6. Key Management Personnel
13.1.6. China Reinsurance (Group) Corporation
13.1.6.1. Company Details
13.1.6.2. Products
13.1.6.3. Financials (As Per Availability)
13.1.6.4. Key Market Focus & Geographical Presence
13.1.6.5. Recent Developments
13.1.6.6. Key Management Personnel
13.1.7. AIA Group Limited
13.1.7.1. Company Details
13.1.7.2. Products
13.1.7.3. Financials (As Per Availability)
13.1.7.4. Key Market Focus & Geographical Presence
13.1.7.5. Recent Developments
13.1.7.6. Key Management Personnel
13.1.8. Azuria Life
13.1.8.1. Company Details
13.1.8.2. Products
13.1.8.3. Financials (As Per Availability)
13.1.8.4. Key Market Focus & Geographical Presence
13.1.8.5. Recent Developments
13.1.8.6. Key Management Personnel
13.1.9. Sino-German Allianz Life Insurance Co., Ltd.
13.1.9.1. Company Details
13.1.9.2. Products
13.1.9.3. Financials (As Per Availability)
13.1.9.4. Key Market Focus & Geographical Presence
13.1.9.5. Recent Developments
13.1.9.6. Key Management Personnel
13.1.10. HSBC Bank (China) Company Limited
13.1.10.1. Company Details
13.1.10.2. Products
13.1.10.3. Financials (As Per Availability)
13.1.10.4. Key Market Focus & Geographical Presence
13.1.10.5. Recent Developments
13.1.10.6. Key Management Personnel
14. Strategic Recommendations/Action Plan
14.1. Key Focus Areas
14.2. Target Type of Coverage
14.3. Target Mode of Purchase
15. About Us & Disclaimer
(Note: The companies list can be customized based on the client requirements.)

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

TechSci Research 社の最新刊レポート


よくあるご質問


TechSci Research社はどのような調査会社ですか?


テックサイリサーチ(TechSci Research)は、カナダ、英国、インドに拠点を持ち、化学、IT、環境、消費財と小売、自動車、エネルギーと発電の市場など、多様な産業や地域を対象とした調査・出版活... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/07/23 10:28

157.74 円

172.13 円

206.60 円

ページTOPに戻る